Be sure to check out the new Product Showcases for
Oral and Maxillofacial Surgeons: |
|
|
Judge Declares Mistrial in First Fosamax Trial
Yahoo! Finance
 A federal judge declared a mistrial in the first trial over whether Merck & Co.'s former blockbuster osteoporosis drug, Fosamax, causes painful jaw bone destruction. Jurors in the month-long trial in New York City had been telling the judge via a series of notes that they couldn't reach a verdict, with one holdout juror accusing others of intimidation. Lawyers waiting in the courtroom could hear loud voices coming from the jury room. More
Periodontitis Associated with Fourfold Increased Risk for Squamous Cell Carcinoma of the Head and Neck
from HemOnc Today via Oral Cancer News
Results of a study involving 473 participants showed that periodontitis was linked with the development of squamous cell carcinoma of the head and neck. Researchers conducted a hospital-based case-control study between June 1999 and November 2005. The study involved 266 patients with head and neck cancer treated at the Roswell Park Cancer Center's department of dentistry and maxillofacial prosthetics, and 207 healthy participants. More
Government Grant Awarded to Extended Oral Cancer Research
from Private MD
Funding made available from the Obama Administration's stimulus plan will assist the UCLA School of Dentistry in cancer research. The National Institutes of Health awarded more than $5 million to UCLA which will be used toward the construction of a state-of-the-art complex designed to expand the School of Dentistry's research on the detection and treatment of oral cancer. More
Review: Erythropoietin Could Harm Some Cancer Patients
from Oncology Nursing News
A new review of data confirms that erythropoietin might be unsafe for people with head and neck cancers who receive the drug in combination with radiation: Radiation patients who were given erythropoietin had poorer outcomes than those who undergoing radiation treatment alone. The hormone erythropoietin is used to combat the anemia suffered by many people undergoing cancer treatment. More
Tooth Decay More Prevalent in Patients with Cleft Lip and/or Palate
from Dental Office Magazine
Patients with cleft lip and/or palate have a higher prevalence of tooth decay and cavities than their siblings without clefts, according to a new report published in the Cleft Palate/Craniofacial Journal. In this study, conducted at Damascus University of Syria, 53 patients with clefts aged 12 to 29 years were compared with 53 sex- and age-matched siblings without clefts. All subjects underwent the same dental examination without X-rays. More
Oral Cancer's New Demographic: 20s and 30s, Non-smokers
from the Houston Dental Health Examiner
Typically, persons at greatest risk for oral cancer were smokers and frequent consumers of alcohol over the age of 50. An increasing number of oral cancer patients, however, have never smoked. Another demographic that is surfacing are persons in their 20s and 30s who were exposed to the human papillomavirus and then developed oral cancer. More
'Complete Symmetry' for Nine-year-old Tania
from The Desert Sun
Tania Regalado Sanchez looks strikingly different than she did 17 days ago. Long, dark ringlets still cascade over the 9-year-old's slender shoulders down her back, and playfulness remains in her eyes. But gone are the slanted nose, stretched mouth and missing jaw that had plagued her since birth. Tania underwent reconstructive surgery to repair her facial deformity and family and friends are elated with the results. More
 |
AAOMS Special Offer
click here for details... The highest standard and most comprehensive in Oral Surgery Patient Education... made better. Easy to understand high quality 3D animations. From wisdom teeth to facial Surgery to dental implants to grafting and more . The new INFORMED CONSENT feature is a "must have " for any Oral Surgeon’s office. Details can be found on the website www.consult-pro.com. Or call for a demo toll free at 1 800 519 6569 ext 2.
|
|
OSSIX™ PLUS™ (resorbable collagen membrane)
 |
The Easy-to-Use Membrane That’s Always Thinking. Experience Excellent Handling for Yourself.
Only OSSIX™ PLUS™ (resorbable collagen membrane) from OraPharma, Inc. has the unique GLYMATRIX™ Cross-Linking Technology, providing the valuable benefits of both better handling and excellent functional integrity. For more information, call 1-866-273-7846 or visit www.orapharma.com.
|
|
|
Pellevé™ Skin Tightening System  Pellevé™ is the newest innovation in skin tightening, recently FDA-cleared
to treat facial wrinkles without surgery. Using radiowaves, the Pellevé
system heats the deep layers of the skin, causing collagen to contract and
tighten. After treatment, the skin begins to produce new collagen, improving
skin firmness and resulting in a naturally refreshed appearance. To learn
more please click here.
|
|
GUIDOR RETURNS!  The first Bioresorbable Matrix Barrier introduced to the U.S. Tissue
Regenerative Market in 1993. GUIDOR™ Matrix has been applied
in over 150,000 surgical sites and has 10 to 12 years of documented
successful case follow ups. In addition, there are over 75 clinical
papers supporting the efficacy of GUIDOR™ Matrix. More info
|
|
Market your practice year-round!  Support professional relationships and increase referral business with Lexi-Comp!
Customize a Lexi-Comp dental handbook or manual with your contact information and message of choice.
Visit Lexi-Comp at AAOMS, Booth # 920 or call 1-800-837-5394 to speak with a bookplate specialist!
More info
|
|
|
Consult-Pro